Bladder Cancer

VI-RADS Scores for Muscle-Invasive Bladder Cancer

Enrique Grande, Head of Oncology at MD Anderson Cancer Center, shared a paper by Giorgio Brembilla et al. on LinkedIn:

Neoadjuvant Chemotherapy VI-RADS Scores for Assessing Muscle-Invasive Bladder Cancer Response to Neoadjuvant Immunotherapy with Multiparametric MRI

Authors: Giorgio Brembilla , Giuseppe Basile, Michele Cosenza, Francesco Giganti, Andrea Del Prete, Tommaso Russo, Renato Pennella, Salvatore Lavalle, Daniele Raggi, Chiara Mercinelli, Valentina Tateo, Antonio Cigliola, Damiano Patanè, Emanuele Crupi, Patrizia Giannatempo, Antonella Messina, Giuseppina Calareso, Alberto Martini, Marco Bandini, Marco Moschini, Gianpiero Cardone, Alberto Briganti, Francesco Montorsi, Andrea Necchi, Francesco De Cobelli

VI-RADS Scores for Muscle-Invasive Bladder Cancer

 

bladder cancer bladder cancer care bladder cancer research cancer Cancer diagnostics cancer outcomes cancer response Enrique Grande imaging in oncology immunotherapy MRI technology multiparametric MRI muscle-invasive cancer neoadjuvant chemotherapy neoadjuvant therapy OncoDaily Oncology oncology advancements oncology biomarkers Precision Medicine treatment assessment VI-RADS